KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hologic (HOLX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to $2.2 billion.

  • Hologic's Cash & Equivalents rose 2165.42% to $2.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year increase of 2165.42%. This contributed to the annual value of $2.0 billion for FY2025, which is 929.08% down from last year.
  • Hologic's Cash & Equivalents amounted to $2.2 billion in Q4 2025, which was up 2165.42% from $2.0 billion recorded in Q3 2025.
  • Over the past 5 years, Hologic's Cash & Equivalents peaked at $2.7 billion during Q3 2023, and registered a low of $816.4 million during Q1 2021.
  • In the last 5 years, Hologic's Cash & Equivalents had a median value of $2.2 billion in 2024 and averaged $1.9 billion.
  • Per our database at Business Quant, Hologic's Cash & Equivalents skyrocketed by 18701.06% in 2022 and then plummeted by 3442.36% in 2025.
  • Quarter analysis of 5 years shows Hologic's Cash & Equivalents stood at $1.4 billion in 2021, then skyrocketed by 71.83% to $2.4 billion in 2022, then fell by 20.86% to $1.9 billion in 2023, then fell by 7.76% to $1.8 billion in 2024, then rose by 21.65% to $2.2 billion in 2025.
  • Its Cash & Equivalents stands at $2.2 billion for Q4 2025, versus $2.0 billion for Q3 2025 and $1.7 billion for Q2 2025.